GxP Global Quality Network is a boutique GxP compliance consulting firm for pharmaceutical, biotechnology, and life sciences organizations, led by Monica Brooks, MSc. The website highlights more than 30 years of industry experience and over 20 years of GxP audit experience, with services available across the United States. Its core positioning is not as a software SaaS provider, but as a high-level audit, regulatory affairs, and quality assurance consulting firm.
Its service coverage is fairly comprehensive. GCP audits include clinical research sites, CROs, sponsor QA systems, TMF, informed consent, IP management, data management, and more. Regulatory affairs support covers FDA strategy, IND, NDA, BLA, ANDA, CMC, post-approval changes, and labeling compliance. On the quality systems side, it supports QMS development, SOPs, CAPA, change control, and deviation management. Inspection readiness services include mock FDA inspections, gap assessments, front room/back room preparation, and responses to 483s and Warning Letters. The website also mentions compliance frameworks such as 21 CFR Part 11, ALCOA+, FDA, and ICH E6.
The website does not publish packages, subscription fees, fixed pricing, or payment methods. Its process starts with an initial consultation, followed by a customized proposal covering scope, deliverables, methodology, and timeline. It then carries out the audit or consulting work and delivers a report with risk ratings, regulatory references, and CAPA recommendations. As such, it is better suited to project-based procurement than to software procurement based on per-account subscriptions.
Its main strength is direct involvement from expert consultants, making it suitable for scenarios with high regulatory risk where defensible audit records and a remediation roadmap are needed. It covers GCP, GLP, GCLP, GVP, FDA submissions, and inspection readiness, offering strong professional depth. The limitations are also clear: it does not present SaaS platform capabilities, and there is no information on APIs, third-party integrations, cloud deployment, self-hosting, permission management, or security certifications. Pricing transparency is limited, and service scalability depends on the resources available through its consultant network.
It is suitable for small and midsize pharmaceutical companies, biotech firms, CROs, and clinical trial sponsors that need external expertise for FDA submissions, clinical quality, QMS remediation, or pre-inspection preparation. For Chinese companies pursuing FDA-facing international submissions, it could be considered as a specialist consulting candidate. If the need is China-local regulatory support, Chinese-language delivery, or a software-based eQMS, local compliance consulting firms or quality management platforms such as Veeva Quality, MasterControl, and Qualio may be better options. The website does not disclose China network accessibility or supported payment methods, so both are considered unknown.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on gxpglobal.com official site.
gxpglobal.com is an United States SaaS Tools provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach gxpglobal.com directly.